Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. - Huttner, N. A.; Girod, A.; Perabo, L.; Edbauer, D.; Kleinschmidt, J. A.; Büning, H.; Hallek, M. (Gene Therapy, 2003)